v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 3,221 $ 8,482
Short-term investments 6,652 0
Accounts receivable 318 1,253
Other current assets 3,339 2,477
Total current assets 13,530 12,212
Property and equipment, net 41 73
Operating lease assets 6,688 7,064
Other assets 765 886
Total assets 21,024 20,235
Current liabilities:    
Accounts payable 824 127
Accrued compensation 699 1,271
Accrued research and development expenses 57 82
Deferred revenue 775 716
Liability related to the sale of future revenues - current portion 1,032 9,750
Other current liabilities 3,460 2,976
Total current liabilities 6,847 14,922
Operating lease liabilities - long-term 8,782 9,347
Liability related to the sale of future revenues - long-term 40,506 32,673
Other long-term liabilities 1,885 1,795
Total liabilities 58,020 58,737
Commitments and contingencies (Note 9)
Stockholders' equity (deficit):    
Common stock - $0.0001 par value, 500,000 shares authorized as of June 30, 2026 and December 31, 2025; 9,443 and 7,324 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 1 1
Additional paid-in capital 1,993,849 1,983,361
Accumulated other comprehensive income (loss) (2) 1
Accumulated deficit (2,030,844) (2,021,865)
Total stockholders' equity (deficit) (36,996) (38,502)
Total liabilities and stockholders' equity (deficit) $ 21,024 $ 20,235

Source

10-Q
HTML PDF
XBRL
ZIP